BridgeMD
Exploratory evaluation of the effect of cholestyramine on serum levels of persistent organic pollutants in obese patients
EU CTIS ID: 2023-505116-37-00
What this study is testing
To evaluate the effect of cholestyramine treatment on serum concentrations of different persistent organic pollutants in a population of obese women of childbearing age for whom bariatric surgery is indicated
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Female patients with an accepted indication for bariatric surgery (BMI > 40 kg/m2 or BMI > 35 kg/m2 with complication(s) improveable by surgery)
- Aged between 18 and 45 years
- Having effective contraception (according to Recommendations related to contraception and pregnancy testing in clinical trials Version 1.2 (CTCG Clinical Trials Coordination Group))
You likely can't join if
- Pregnant or breastfeeding women
- Known allergy or intolerance to cholestyramine
- Chronic constipation
- Chronic disease that may interfere with the efficacy of treatment (unbalanced diabetes with HbA1c >7%, known and treated dyslipidaemia, chronic renal failure with GFR <60 ml/min, hepatocellular failure)
- Phenylketonuria
- Patients on anti-vitamin K, digoxin, levothyroxine or likely to be on such therapy within 3 months of inclusion.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.